Market revenue in 2023 | USD 104.7 million |
Market revenue in 2030 | USD 85.5 million |
Growth rate | -2.9% (CAGR from 2023 to 2030) |
Largest segment | Hospitals |
Fastest growing segment | Home Care |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care |
Key market players worldwide | Becton Dickinson & Co, BioMerieux SA, Bio-Rad Laboratories Inc, Abbott Laboratories, Agilent Technologies Inc, Danaher Corp, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Roche Holding AG, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to molecular diagnostics market will help companies and investors design strategic landscapes.
Hospitals was the largest segment with a revenue share of 46.99% in 2023. Horizon Databook has segmented the Sweden molecular diagnostics market based on hospitals, outpatient facilities, home care covering the revenue growth of each sub-segment from 2018 to 2030.
Cancer is one of the leading causes of mortality in Sweden. According to Globocan 2020, 24,464 cancer deaths occurred in the country, and approximately 62,494 new cancer cases were diagnosed. The Swedish government introduced the new EU Cancer Plan to reduce the burden of cancer.
This plan emphasized improving the treatment of cancer. This was expected to improve the demand for molecular diagnostics for use in cancer over the forecast period. However, the negative CAGR of the market is attributable to the impact of COVID-19.
Increasing EUA of diagnostic tests due to the rising incidence of COVID-19 is anticipated to accelerate market growth amid the pandemic. For instance, Mobidiag Ltd. is in the process of receiving EUA for the Amplidiag COVID-19 test in Sweden.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Sweden molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account